United States · Investor

Pfizer

Last cheque observed Jun 2026; 84 cheques on record.

Deploying nowCorporate VC

SeedSeries ASeries BAppsLocal AdvertisingMedical Device

Deploying now
100%of best year3cheques in 12 months, 84 on record
Since the last cheque135days00hrs00min00sec
Median round$51MRounds led4 of 84Sole investor9 roundsExits7 from the portfolioMostly inUnited States, 79%
Pitch Pfizer

Pfizer highlights

  1. 01

    3 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 69% of its rounds

  3. 03

    Sole investor in 9 rounds, median $7.0M

  4. 04

    7 exits from the portfolio

What they do

The page mentions 'Venture Investments' under 'Research and Business Development Partnerships', indicating a corporate venture capital arm.From their own website
Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
AppsLocal AdvertisingMedical Device
Based in
New York, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first84 appearances

  1. 2026

    3 rounds

  2. Jun
    COUR PharmaSeries B · US · Lumira Ventures$50MWith 7 others
  3. May
    CellCentricGrowth · Ventureburn$220MWith 6 others
  4. Apr
    Storm TherapeuticsSeries C · Fast Track Initiative$56MWith 5 others
  5. 2024

    2 rounds

  6. Nov
    TRex BioSeries B · US · Avego Management$84MWith 8 others
  7. Mar
    Capstan TherapeuticsSeries B · US · Firms' own news pages$175MWith 15 others
  8. 2019

    9 rounds

  9. Dec
    Tripley TherapeuticsSeries A · US · FinSMEs$59MWith 1 other
  10. Dec
    ImmunOSSeries A · CH · FinSMEs$15MLed
  11. Dec
    ImCheck TherapeuticsSeries B · FR · FinSMEs$53MLed
  12. Nov
    ArkudaSeries A · US · FinSMEs$44MLed
  13. May
    Storm TherapeuticsSeries A · GB · FinSMEs$18MWith 4 others
  14. Apr
    Arrakis TherapeuticsSeries B · US · FinSMEs$75MWith 13 others
  15. Apr
    SpringWorks TherapeuticsSeries B · US · FinSMEs$125MWith 12 others
  16. Mar
    Vivet TherapeuticsFR · FinSMEs$51MSole investor
  17. Feb
    GliknikUS · Technical$15MSole investor
  18. 2018

    8 rounds

  19. Nov
    Kymera TherapeuticsSeries B · US · FinSMEs$65MLed
  20. Sept
    4D MolecularSeries B · US · Endpts$90MWith 9 others
  21. Aug
    Magnolia NeuroscienceSeries A · US · FinSMEs$31MWith 10 others
  22. Aug
    TherachonSeries B · CH · FinSMEs$60MWith 8 others
  23. Jun
    NimbusUS · FinSMEs$65MWith 6 others
  24. May
    CortexymeSeries B · US · FinSMEs$76MWith 10 others
  25. May
    StrataSeries B · US · FinSMEs$26MWith 5 others
  26. Apr
    RefleXionSeries C · US · FinSMEs$100MWith 6 others
  27. 2017

    9 rounds

  28. Oct
    CydanUS · FinSMEs$34MWith 5 others
  29. Oct
    PalleonSeries A · US · FinSMEs$48MWith 4 others
  30. Sept
    SpringWorksSeries A · US · FinSMEs$103MWith 4 others
  31. Jun
    NeuroneticsSeries G · US · FinSMEs$15MWith 11 others
  32. Apr
    AquinnahUS · FinSMEs$10MWith 1 other
  33. Feb
    Arrakis TherapeuticsSeries A · US · FinSMEs$38MWith 4 others
  34. Feb
    RhythmUS · FinSMEs$41MWith 6 others
  35. Jan
    AmraSE · FinSMEs$9.0MWith 3 others
  36. Jan
    Molecular StethoscopeSeed · US · FinSMEs$8.2MWith 2 others
  37. 2016

    2 rounds

  38. Sept
    AnTolRxSeries A · US · FinSMEs$4.0MSole investor
  39. Jun
    Morphic TherapeuticSeries A · US · Businesswire$52MWith 1 other
  40. 2015

    7 rounds

  41. Aug
    Rhythm PharmaceuticalsSeries A · US$40MWith 7 others
  42. Jul
    Autifony TherapeuticsSeries A · GB$12MWith 4 others
  43. Apr
    NeuroneticsSeries F · US$34MWith 7 others
  44. Apr
    MerusSeries C · NL$79MWith 10 others
  45. Mar
    Nimbus TherapeuticsSeries B · US$43MWith 5 others
  46. Mar
    Mersana TherapeuticsSeries B · US$35MWith 4 others
  47. Jan
    CytomX TherapeuticsSeries C · US$20MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 23 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

5+funds on filenumbered funds in its name

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

DVS SciencesBought by Fluidigm$208MJan 2014
Five Prime TherapeuticsListedUndisclosedJul 2013
SuperDimensionBought by Covidien$300MMar 2012
ICAgenBought by Pfizer$56MOct 2011
Avid RadiopharmaceuticalsBought by Eli Lilly$800MNov 2010
HandyLabBought by Becton Dickinson$275MOct 2009
Coley Pharmaceutical GroupBought by PfizerUndisclosedNov 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Allergan$160BNov 2015
Hospira$15BFeb 2015
RedvaxUndisclosedJan 2015
Baxter International$635MJul 2014
InnoPharma$225MJul 2014
NextWave PharmaceuticalsUndisclosedOct 2012
ICAgen$56MOct 2011
King Pharmaceuticals$3.6BOct 2010
Foldrx PharmaceuticalsUndisclosedSept 2010
Wyeth Pharmaceuticals$68BJan 2009
SerenexUndisclosedMar 2008

Who they invest alongside

The investors most often in the same rounds as Pfizer. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Pfizer put money into.

Quick answers about Pfizer

What does Pfizer invest in?

Pfizer invests most often at Series B and Series A (69% of the rounds on record), in sectors such as Apps, Local Advertising and Medical Device.

How active is Pfizer?

84 investments on record, 3 of them in the last 12 months, and it led 4. The most recent was in Jun 2026.

What has Pfizer invested in recently?

Its most recent investments on record: COUR Pharma (Series B, Jun 2026), CellCentric (Growth, May 2026) and Storm Therapeutics (Series C, Apr 2026).

How big are Pfizer's cheques?

The median round it joins is $51M.

Does Pfizer lead rounds?

Sometimes: it led 4 of its 84 investments on record (5%).

Where does Pfizer invest?

Most of the companies it backs are in the United States (79%), Switzerland (5%) and France (5%).

Is Pfizer investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

Who does Pfizer invest alongside?

Most often New Enterprise Associates (13 rounds together), Alexandria Real Estate Equities (7 rounds together) and OrbiMed (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it